Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Generalized Anxiety Disorder (GAD): full-pipeline trial registry
5 of 7 indexed Generalized Anxiety Disorder (GAD) trials are currently recruiting.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 5 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Generalized Anxiety Disorder (GAD): 7 US clinical trials tracked, 5 recruiting.
Generalized Anxiety Disorder (GAD) is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is AbbVie, running 2 of these trials.
Enrollment posture brief
Registry condition generalized-anxiety-disorder-gad
OPEN 5 | RECR 71% | LATE 2 | EARLY 2 | RANK #2497 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Advanced Endometrial Carcinoma (71% recruiting · 7 trials)
Generalized Anxiety Disorder (GAD) lists 5 open slots (71% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Generalized Anxiety Disorder (GAD) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Generalized Anxiety Disorder (GAD) is recruiting above its size-band peers.
5 of 7 indexed trials (71.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Generalized Anxiety Disorder (GAD) research.
AbbVie accounts for 2 of 7 trials (28.6%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Generalized Anxiety Disorder (GAD) enrolment sits around 106 participants.
Median target enrolment is 106 among the 7 trials that report a genuine target (sentinel values excluded). 3 of those (42.9%) plan for fewer than 100 participants.
-
Generalized Anxiety Disorder (GAD) research is mostly interventional.
7 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
AbbVie
NCT06846320
Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCD
Baylor College of Medicine
NCT07024758
Stepped Care Treatment for Anxiety Resilience
Andrew Wiese
NCT07228143
Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder
Wayne State University
NCT07123467
Targeting Social Function in Anxiety and Eating Disorders
University of Texas Southwestern Medical Center
NCT06198023
EDG004 Treatment of Adult Patients With Generalized Anxiety Disorder (GAD)
Edgemont Pharmaceuticals
NCT02305797
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ABBV-932 in Healthy Adult Participants, Participants With Generalized Anxiety Disorder (GAD) and Participants With Bipolar Disorder (BPD)
AbbVie
NCT06024239
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Generalized Anxiety Disorder (GAD) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Generalized Anxiety Disorder (GAD) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Generalized Anxiety Disorder (GAD) page
7 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Generalized Anxiety Disorder (GAD) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- AbbVie sponsors the most Generalized Anxiety Disorder (GAD) trials on record, review their full trial history before evaluating a specific study. See AbbVie's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Generalized Anxiety Disorder (GAD) condition card totals 7 registered trials; most-linked intervention Placebo for ABBV-932; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.